Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA

Rang in Aktien #35791
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Aktienkurs
$0.016
Zuletzt synchronisiert: 2024-03-11
Marktkapitalisierung
$3.27M
Veränderung (1 Tag)
-5.33%
Veränderung (1 Jahr)
5,233.33%
Land
US
Handel Invitae Corporation (NVTA)

Kategorie

Healthcare
EPS für Invitae Corporation (NVTA)
EPS zum September 2023 TTM: $-5.38
Laut den aktuellen Finanzberichten und dem Aktienkurs von Invitae Corporation beträgt das aktuelle EPS des Unternehmens (TTM) $-5.38. Am Ende des Jahres 2022 betrug das EPS $-13.18 eine Steigerung gegenüber dem EPS von 2021, das $-1.80 betrug.
EPS-Verlauf von Invitae Corporation von 2016 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-5.38 -100.00%
2023 0.00 -100.00%
2022 $-13.18 632.22%
2021 $-1.80 -59.73%
2020 $-4.47 68.05%
2019 $-2.66 37.11%
2018 $-1.94 -26.79%
2017 $-2.65 -12.25%
2016 $-3.02 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$18.62 -446.10%
US
$5.65 -205.02%
US
$-1.36 -74.72%
US
- -
CN
$5.09 -194.61%
US